Expanding the DLBCL Toolbox with Bispecific Antibodies - CME

CME

Description: Bispecific antibodies are rapidly changing the treatment landscape for diffuse large B-cell lymphoma (DLBCL), yet many clinicians are not fully up to date on emerging clinical data or how best to integrate these agents across lines of therapy. It can also be difficult to recognize and manage treatment-related toxicities, which can limit safe and effective use in practice. Join us for a CME activity that will provide hematologists, oncologists, advanced practice providers, and nurses with practical, evidence-based guidance on the use of bispecific antibodies in DLBCL. Using patient case studies, participants will gain strategies for patient selection, treatment sequencing, and team-based management of adverse events to support optimal patient outcomes.

Target Audience: The primary target audience for this activity are hematologists/oncologists, nurses/nurse practitioners, physician assistants, and other health care professionals (HCPs)

Learning Objectives

Evaluate current and emerging bispecific antibodies for the management of relapsed/refractory diffuse large B-cell lymphoma
Review the rationale for the effective use of bispecific antibodies in frontline diffuse large B-cell lymphoma
Develop team-based strategies to manage and mitigate adverse events associated with bispecific antibodies

Disclosures and Disclaimers: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accredited Providers

Commercial Support

Credit Information

Credit Type	Units / Unit Type	Board
AMA PRA Category 1 Credit	1 Credits	ACCME- Accreditation Council for Continuing Medical Education